Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00004738
Other study ID # 000089
Secondary ID 00-N-0089
Status Completed
Phase
First received
Last updated
Start date June 4, 2001

Study information

Verified date May 9, 2024
Source National Institutes of Health Clinical Center (CC)
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of this study is to better understand the genetic factors related to the Chiari I malformation. In people with this abnormality, the lower part of the skull is smaller than normal. As a result, the lowest part of the brain, called the cerebellar tonsils, protrudes out of the hole at the bottom of the skull into the spinal canal. This study will try to discover the location of the genes responsible for the malformation. Candidates for this study are: 1) Patients with Chiari I malformation who also have a family member with the abnormality or a family member with syringomyelia (a cyst in the spinal cord that is often associated with the Chiari I malformation). 2) Family members of patients with the Chiari I malformation. Participants will have a medical history and physical and neurologic examinations. They will undergo magnetic resonance imaging (MRI) of the brain and cervical (neck) spinal cord to measure the size of the head and determine the presence of the Chiari I malformation and syringomyelia. A small blood sample (about 2 tablespoons) will be drawn for DNA studies relating to the Chiari I malformation.


Description:

Objectives: The goal of this study is to establish family pedigrees and undertake genetic linkage analysis that will identify gene loci associated with the Chiari I malformation and underdevelopment of the bone forming the posterior cranial fossa. Study Population: Patients and family members of patients with the Chiari I malformation. Because the research institutions are located in the United States and Russia, subjects will be recruited predominantly from these countries. Design: Human subjects will undergo 1) neurologic examinations, 2) head and cervical MRI scans to evaluate for the Chiari I malformation, syringomyelia, and maldevelopment of the posterior fossa, and 3) isolation and analysis of genomic DNA from whole blood for linkage analysis. Outcome Measures: Pedigrees will be established based on the MRI findings. The Chiari I phenotype will be defined as the caudal portion of the cerebellar tonsils lying greater than or equal to 2 mm below the foramen magnum and underdevelopment of the bone of the posterior fossa will be defined as 1) obliteration of the CSF pathways in the inferior portion of the posterior fossa, 2) posterior fossa volume to supratentorial volume ratio of less than or equal to 15%, or 3) abnormal shortening of the bones of the skull base. Genetic analysis of the genomic DNA will be performed with DNA polymorphic markers to identify chromosomal loci linked to the small posterior fossa phenotype. A lod score of 3.0 (equivalent to 1000:1 odds in favor of linkage) will be taken as proof that the Chiari I gene maps to the same genetic region of the human genome as a given DNA marker.


Recruitment information / eligibility

Status Completed
Enrollment 152
Est. completion date
Est. primary completion date
Accepts healthy volunteers No
Gender All
Age group 1 Year and older
Eligibility - INCLUSION CRITERIA: To be eligible for entry into the study, a candidate must meet the following criteria: Patient with a confirmed diagnosis of Chiari I malformation who has a family member with syringomyelia or Chiari I malformation, or Family member of a patient with a confirmed diagnosis of Chiari I malformation, AND There are at least two family members diagnosed with Chiari I malformation. If an adult, able to give informed consent; if a minor, has an adult who is legally responsible for the subject and who is able to give consent. EXCLUSION CRITERIA: A candidate will be excluded if he/she: Has a contraindication to MRI scanning. Is unable to comprehend the risks of the testing. Is less than one year of age. Cannot undergo MRI scanning without sedation.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Russian Federation Kazan State Medical University Kazan
United States National Institutes of Health Clinical Center Bethesda Maryland

Sponsors (1)

Lead Sponsor Collaborator
National Institute of Neurological Disorders and Stroke (NINDS)

Countries where clinical trial is conducted

United States,  Russian Federation, 

Outcome

Type Measure Description Time frame Safety issue
Primary Family Pedigree/Genetic Linkage Establish family pedigrees and undertake genetic linkage analysis that will identify gene loci associated with the Chiari I malformation andunderdevelopment of the bone forming the posterior cranial fossa. ongoing
Primary Genetic Analysis Genetic analysis of the genomic DNA will be performed with DNA polymorphic markers to identify chromosomal loci linked to the Chiari I and small posterior fossa phenotype. Genetic Analysis ongoing
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06011226 - Development of a Patient-reported Outcome Measure for Chiari Malformation and Syringomyelia
Recruiting NCT06308367 - The Therapeutic Effect of Betaine in Syringomyelia Phase 2
Completed NCT04220541 - Investigation of the Effects of Exercise on Patients With Chiari Malformation N/A
Completed NCT00001327 - Establishing the Physiology of Syringomyelia N/A
Completed NCT00011245 - Study and Surgical Treatment of Syringomyelia N/A
Completed NCT02341950 - Clinical Trial of a Serious Game for Individuals With SCI/D N/A
Recruiting NCT06268093 - The Therapeutic Effect of Thalidomide in Syringomyelia Phase 2
Not yet recruiting NCT05646810 - Impact of Peripheral Afferent Input on Central Neuropathic Pain N/A
Active, not recruiting NCT01150708 - A Prospective Natural History Study of Patients With Syringomyelia
Recruiting NCT06375759 - Subarachnoid-Subarachnoid (S-S) Bypass Versus Adhesion Lysis in Spinal Arachnoiditis and Syringomyelia N/A
Completed NCT02669836 - Posterior Fossa Decompression With or Without Duraplasty for Chiari Type I Malformation With Syringomyelia N/A